Physician

Alexander Vartanov, MD

According to 2025 Medicare claims, Alexander Vartanov, MD (NPI: 1073019717) practices medical oncology in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Philadelphia, PA. This provider's primary affiliated billing organization is TEMPLE FACULTY PRACTICE PLAN, INC (NPI: 1417430166; TIN: 831002191) and primary practice location at 19111-2442.

Vartanov's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 44 traditional Medicare patients, billed 228 HCPCS/CPT codes, and received $17,455 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 333 prescription claims across 65 beneficiaries totaling $1,286,539 in drug costs, led by Jakafi (Ruxolitinib Phosphate). Open Payments data shows 3 records totaling $128. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $2,664 to $1,286,539. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$8.7K$17K2024 Medicare payment: $17,455 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
202444228$17,455

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$643K$1.3M2018 Drug cost: $2,664 (USD; Tot_Drug_Cst)2019 Drug cost: $25,604 (USD; Tot_Drug_Cst)2020 Drug cost: $84,354 (USD; Tot_Drug_Cst)2021 Drug cost: $64,477 (USD; Tot_Drug_Cst)2022 Drug cost: $532,522 (USD; Tot_Drug_Cst)2023 Drug cost: $389,969 (USD; Tot_Drug_Cst)2024 Drug cost: $1,286,539 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20182052$2,664
201964384$25,604
202073418$84,354
202157334$64,477
202292265$532,522
2023112484$389,969
202465333$1,286,539

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more1433$105
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes29142$63

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
JakafiRuxolitinib Phosphate13390$210,876
GabapentinGabapentin361,140$726
AcyclovirAcyclovir441,290$695
Levothyroxine SodiumLevothyroxine Sodium18660$238
Pantoprazole SodiumPantoprazole Sodium11390$40

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.3$128Kite Pharma, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Alexander Vartanov, MD?

Tedicare shows public-source Medicare data for Alexander Vartanov, MD (NPI 1073019717), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alexander Vartanov, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alexander Vartanov, MD?

Alexander Vartanov, MD is linked to TEMPLE FACULTY PRACTICE PLAN, INC (billing NPI 1417430166) in the available physician profile data.

Does Alexander Vartanov, MD have Open Payments data?

Alexander Vartanov, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.